Enliven Therapeutics (ELVN) P/E (2020 - 2026)
Enliven Therapeutics (ELVN) P/E from Mar 31, 2020 to Jul 21, 2026. The TTM Enliven Therapeutics (ELVN) P/E is -32.83. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Enliven Therapeutics (ELVN)
| Year | P/E | Change |
|---|---|---|
| 2026 | -32.83 | +294.13% |
| 2025 | -8.33 | -30.67% |
| 2024 | -12.01 | +44.95% |
| 2023 | -8.29 | -18.23% |
| 2022 | -10.14 | +168.19% |
| 2021 | -3.78 | -89.74% |
| 2020 | -36.83 | N/A |
Comparison Enliven Therapeutics (ELVN) P/E with competitors
Enliven Therapeutics (ELVN) P/E is -32.83.